scholarly journals A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot consortium trial (ADVL1315)

Cancer ◽  
2018 ◽  
Vol 124 (23) ◽  
pp. 4548-4555 ◽  
Author(s):  
James I. Geller ◽  
Elizabeth Fox ◽  
Brian K. Turpin ◽  
Stuart L. Goldstein ◽  
Xiaowei Liu ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Children And Adolescents ◽  
Solid Tumors ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitor ◽  
Phase 1 ◽  
Vegf Receptor ◽  
Oncology Group ◽  
Receptor Tyrosine Kinase Inhibitor

P-359 Results from a phase I study of the oral VEGF receptor tyrosine kinase inhibitor ZD6474, in patients with solid tumors

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S182
Author(s):  
Catherine Wheeler ◽  
Hironobu Minami ◽  
Hiromichi Ebi ◽  
Makoto Tahara ◽  
Yasutsuna Sasaki ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Phase I ◽  
Tyrosine Kinase Inhibitor ◽  
Solid Tumors ◽  
Receptor Tyrosine Kinase ◽  
Phase I Study ◽  
Kinase Inhibitor ◽  
Vegf Receptor ◽  
Receptor Tyrosine Kinase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document